**Core Concept**
The question is testing the understanding of the role of cyclooxygenase-2 (COX-2) inhibitors in the inflammatory process. COX-2 is an enzyme responsible for the conversion of arachidonic acid into prostaglandin H2, a key mediator of inflammation.

**Why the Correct Answer is Right**
COX-2 inhibitors work by selectively blocking the COX-2 enzyme, thereby reducing the production of prostaglandins and thromboxanes. This action leads to a decrease in the inflammatory response, as prostaglandins are involved in mediating pain, fever, and inflammatory responses. The correct answer is related to the step in the inflammatory process where COX-2 is involved.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because COX-2 inhibitors do not affect the production of leukotrienes, which are involved in the inflammatory response but are produced through a different pathway.

**Option B:** This option is incorrect because COX-2 inhibitors do not directly affect the activation of NF-κB, a transcription factor involved in the inflammatory response.

**Option C:** This option is incorrect because COX-2 inhibitors do not directly affect the production of cytokines, which are signaling molecules involved in the inflammatory response.

**Clinical Pearl / High-Yield Fact**
COX-2 inhibitors are a class of nonsteroidal anti-inflammatory drugs (NSAIDs) that are designed to reduce the gastrointestinal side effects associated with traditional NSAIDs. By selectively inhibiting COX-2, these medications can reduce the production of prostaglandins in the gastrointestinal tract, leading to a lower risk of gastrointestinal bleeding and ulcers.

**Correct Answer:** B. Inhibition of COX-2 enzyme activity.